Introduction to Part 1
- PMID: 33534472
- Bookshelf ID: NBK566167
Introduction to Part 1
© International Agency for Research on Cancer, 2019. For more information contact publications@iarc.fr.
Sections
Similar articles
-
Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study.Lancet Rheumatol. 2022 Apr;4(4):e262-e273. doi: 10.1016/S2665-9913(22)00008-X. Epub 2022 Feb 25. Lancet Rheumatol. 2022. PMID: 38288922
-
The impact of the congestion charging scheme on air quality in London. Part 1. Emissions modeling and analysis of air pollution measurements.Res Rep Health Eff Inst. 2011 Apr;(155):5-71. Res Rep Health Eff Inst. 2011. PMID: 21830496
-
Machine Learning in Nuclear Medicine: Part 1-Introduction.J Nucl Med. 2019 Apr;60(4):451-458. doi: 10.2967/jnumed.118.223495. Epub 2019 Feb 7. J Nucl Med. 2019. PMID: 30733322 Review.
-
Hydroids (Cnidaria, Hydrozoa) from Mauritanian Coral Mounds.Zootaxa. 2020 Nov 16;4878(3):zootaxa.4878.3.2. doi: 10.11646/zootaxa.4878.3.2. Zootaxa. 2020. PMID: 33311142
-
Introduction to the medication regimen review--part 3.Consult Pharm. 2011 Jan;26(1):16-27. doi: 10.4140/TCP.n.2011.16. Consult Pharm. 2011. PMID: 21224196 Review.
References
Publication types
LinkOut - more resources
Full Text Sources